154
Views
33
CrossRef citations to date
0
Altmetric
Perspective

Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up

Pages 515-524 | Published online: 09 Jan 2014

References

  • Müller HL. Review: Childhood Craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm. Res.69(4), 193–202 (2008).
  • Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J. Neurosurg.89, 547–551 (1998).
  • Müller-Scholden J, Lehrnbecher T, Müller HL et al. Radical surgery in a neonate with craniopharyngioma. Pediatr. Neurosurg.33, 265–269 (2001).
  • Rushing EJ, Giangaspero F, Paulus W, Burger PC. Craniopharyngioma. In: Pathology and Genetics of Tumours of the Central Nervous System – WHO Classification of Tumours of the Central Nervous System. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK (Eds). IARC, Lyon, France (2007).
  • Müller HL, Emser A, Faldum A et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J. Clin. Endocrinol. Metab.89, 3298–3305 (2004).
  • Warmuth-Metz M, Gnekow AK, Müller H, Sörensen L. Differential diagnosis of suprasellar tumors in children. Klin. Padiatr.216, 323–330 (2004).
  • Choux M, Lena G, Genitori L. Craniopharyngioma in children. Neurochirurgie37(Suppl. 1), 1–174 (1991).
  • Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical management of craniopharyngiomas: experience with 168 patients. J. Neurosurg.90, 237–250 (1999).
  • Merchant TE, Kiehna EN, Kun LE et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J. Neurosurg.104(2 Suppl.), 94–102 (2006).
  • Einhaus SL, Sanford RA. Craniopharyngiomas. In: Principles and Practice of Pediatric Neurosurgery. Albright AL, Pollack, IF, Adelson PD, Matsushima Y (Eds). Thieme Medical Publishers, NY, USA 545–562 (1999).
  • Puget S, Garnett M, Wray A et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J. Neurosurg.106(1 Suppl.), 3–12 (2007).
  • Gupta DK, Ojha BK, Sarkar C et al. Recurrence in craniopharyngiomas: analysis of clinical and histological features. J. Clin. Neurosci.13, 438–442 (2006).
  • Merchant TE, Kiehna EN, Sanford RA et al. Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int. J. Radiat. Oncol. Biol. Phys.53(3), 533–542 (2002).
  • Garrè ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr. Opin. Pediatr.19, 471–479 (2007).
  • Müller HL, Kaatsch P, Warmuth-Metz M et al. Childhood craniopharyngioma – diagnostic and therapeutic strategies. Monatsschr. Kinderheilkd.151, 1056–1063 (2003).
  • Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital. Childs Nerv. Syst.21, 729–746 (2005).
  • Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J. Neurosurg.73, 3–11 (1990).
  • Müller HL. More or less? Treatment strategies in childhood craniopharyngioma. Childs Nerv. Syst.22, 156–157 (2006).
  • Müller HL, Sörensen N. KRANIOPHARYNGEOM 2000 – Multizentrische, Prospektive Beobachtungsstudie von Kindern und Jugendlichen mit Kraniopharyngeom. Müller HL (Ed.). Verlag Isensee, Oldenburg, Germany (2001).
  • Müller HL, Gebhardt U, Schröder S et al. Analyses of treatment variables for patients with childhood craniopharyngioma – results of the multicenter prospective study KRANIOPHARYNGEOM 2000. Horm. Res.73, 175–180 (2010).
  • Sanford RA. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr. Neurosurg.21(Suppl. 1), 39–43 (1994).
  • Wolff JE, Daumling E, Dirksen A, Dabrock A, Hartmann M, Jürgens H. Münster Heidelberg abilities scale – a measuring instrument for global comparison of illness sequelae. Klin. Padiatr.208, 294–298 (1996).
  • Ierardi DF, Fernandes MJ, Silva IR et al. Apoptosis in α interferon (IFN-α) intratumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv. Syst.23(9), 1041–1046 (2007).
  • Riva D, Pantaleoni C, Devoti M, Saletti V, Nichelli F, Giorgi C. Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngeoma. Childs Nerv. Syst.14, 179–184 (1998).
  • Pierre-Kahn A, Recassens C, Pinto G et al. Social and psycho–intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective series. Childs Nerv. Syst.21, 817–824 (2005).
  • Müller HL, Bruhnken G, Emser A et al. Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv. Syst.21, 975–980 (2005).
  • Müller HL, Gebhardt U, Faldum A et al. Functional capacity and body mass index in patients with sellar masses – cross-sectional study on 403 patients diagnosed during childhood and adolescence. Childs Nerv. Syst.21, 539–545 (2005).
  • Fisher PG, Jenab J, Goldthwaite PT et al. Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv. Syst.14, 558–563 (1998).
  • DeVile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch. Dis. Child.75, 108–114 (1996).
  • Merchant TE, Goloubeva O, Pritchard DL et al. Radiation dose–volume effects on growth hormone secretion. Int. J. Radiat. Oncol. Biol. Phys.52(5), 1264–1270 (2002).
  • Honegger J, Buchfelder M, Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. J. Neurosurg.90, 251–257 (1999).
  • Müller HL. Childhood craniopharyngioma – current strategies in laboratory diagnostics and endocrine treatment. Lab. Med.27, 377–385 (2003).
  • Lustig RH, Post SR, Srivannaboon K et al. Risk factors for the development of obesity in children surviving brain tumours. J. Clin. Endocrinol. Metab.88(2), 611–616 (2003).
  • Müller HL, Bueb K, Bartels U et al. Obesity after childhood craniopharyngioma – German multicenter study on preoperative risk factors and quality of life. Klin. Padiatr.213, 244–249 (2001).
  • Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. J. Clin. Endocrinol. Metab.89, 81–86 (2004).
  • Müller HL, Schneider P, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N. Volumetric bone mineral density (BMD) in patients with childhood craniopharyngioma. Exp. Clin. Endocrinol. Diabetes111, 168–173 (2003).
  • Müller HL, Heinrich M, Bueb K et al. Perioperative dexamethasone treatment in childhood craniopharyngioma – influence on short-term and long-term weight development. Exp. Clin. Endocrinol. Diabetes.111, 330–334 (2003).
  • De Vile CJ, Grant DB, Kendall BE et al.Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J. Neurosurg.85, 73–81 (1996).
  • De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BGR, Stanhope R. Obesity in childhood craniopharyngioma: Relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J. Clin. Endocrinol. Metab.81, 2734–2737 (1996).
  • Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinemia and a failure in the down regulation of appetite. Eur. J. Endocrinol.138, 89–91 (1998).
  • Harz KJ, Müller HL, Waldeck E, Pudel V, Roth C. Obesity in patients with craniopharyngioma: assessment of physical activity and food intake. J. Clin. Endocrinol. Metab.88, 5227–5231 (2003).
  • Müller HL, Handwerker G, Wollny B, Faldum A, Sörensen N. Melatonin secretion and increased sleepiness in childhood craniopharyngioma. J. Clin. Endocrinol. Metab.87, 3993–3996 (2002).
  • Müller HL, Handwerker G, Gebhardt U et al. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control17, 583–589 (2006).
  • Müller HL, Müller-Stöver S, Gebhardt U, Kolb R, Sörensen N, Handwerker G. Secondary narcolepsy may be an underrated cause of increased daytime sleepiness in obese patients after childhood craniopharyngioma. J. Pediatr. Endocrinol. Metab.19, 423–429 (2006).
  • Mason PW, Krawiecki N, Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch. Pediatr. Adolesc. Med.156, 887–892 (2002).
  • Lustig RH, Hinds PS, Ringwald-Smith K et al. Octreotide therapy of pediatric hypothalamic obesity: a doubleblind, placebo-controlled trial. J. Clin. Endocrinol. Metab.88, 2586–2592 (2003).
  • Roth C, Hunneman D, Gebhardt U, Stoffel-Wagner B, Reinehr T, Müller HL. Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr. Res.61, 496–501 (2006).
  • Müller HL, Gebhardt U, Wessel V et al. First experiences with laparoscopic gastric banding (LAGB) in the treatment of obese patients with childhood craniopharyngioma. Klin. Padiatr.219, 323–325 (2007).
  • Lustig RH, Tsai P, Hirose S, Farmer DL. Treatment of hypothalamic obesity by laparoscopic truncal vagotomy: early experience. Presented at: LWPES/ESPE 8th Joint Meeting. New York, NY, USA, 9–12 September 2009. Horm. Res.72(Suppl. 3), 48 (2009) (Abstract FC11–011).
  • Roth CL, Enriori PJ, Gebhardt U et al. Changes of peripheral α-MSH in childhood obesity. Metabolism59(2), 186–194 (2010).
  • Müller HL, Faldum A, Etavard-Gorris N et al. Functional capacity, obesity and hypothalamic involvement – crosssectional study on 212 patients with childhood craniopharyngioma. Klin. Padiatr.215, 310–314 (2003).
  • Müller HL, Gebhardt U, Etavard-Gorris N et al. Prognosis and sequela in patients with childhood craniopharyngioma – results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin. Padiatr.216, 343–348 (2004).
  • Müller HL, Gebhardt U, Pohl F et al. Relapse pattern after complete resection and early progressions after incomplete resection of childhood craniopharyngioma – update on KRANIOPHARYNGEOM 2000 and design of KRANIOPHARYNGEOM 2007. Klin. Padiatr.218, 315–320 (2006).
  • Müller HL, Gebhardt U, Etavard-Gorris N, Kolb R, Sörensen N. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up – recommendations in KRANIOPHARYNGEOM 2000. Onkologie28, 150–156 (2004).
  • Müller HL, Albanese A, Calaminus G et al. Consensus and perspectives on treatment strategies in childhood craniopharyngioma – results of a meeting of the craniopharyngioma study group (SIOP), Genova 2004. J. Pediatr. Endocrinol. Metab.19, 453–454 (2006).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.